HF/Cardiogenic Shock Flashcards

1
Q

S3

A

-Signifies vent failure from over stretching
“Sloshing-in” S1-S2-S3
-systolic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

S4

A

“A-stiff-wall” S4-S1-S2

  • sound of forced blood from atria into non compliant ventricular
  • diastolic HF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Common causes of HF

A

CAD-long term dec O2 supply
HTN - increase vent work long term, hypertrophy
Valve deformities - valve stenosis - fixed afterload increases workload of heart
Cardiomyopathies - dec contractility, remodelling
Kidney dx - over stretched overworked heart from preload and chronic raas

All cause chronic activation of SNS AND RAAS in compensating for resultant dec CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of HF

A

1.
-chronic - oupt, stable symptoms, meds to manage o2s/d beta blockers, ACEi etc
-acute decompensated - sudden onset, o2s/d imbalance, ie. MI, myocarditis, deterioration of chronic HF
2.
-Systolic - baggy distended L ventricle, dec CO from ineffective contractility, inc preload/afterload exacerbating, dec EF, low BP. S3 audible.
-Diastolic - vent hypertrophy, stiff non complaint vent, EF preserved but dec CO from dec preload present in smaller ventricular interior. Inc afterload from SNS/RAAS will exacerbate and cause HTN, prone to flash pulm edema, as no space in LV to inc preload. S4 audible.

e.g. “Acute decompensated Diastolic HF”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiological Causes of Chronic HF symptoms

A
  • Ventricular Remodeling - myocytic remodeling in response to injury/scarring/compensatory neurohormones
  • Apoptosis - cell death from ischemia, causes scar tissue, decreased contractility, ectopic rhythms
  • abnormal hypertrophy of myocytes - from chronic activation of SNS and RAAS

Neurohormonal action in SNS and RAAS cause damage to heart from ongoing demand and ischemia together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Natriuretic peptides

A

Atrial and Ventricular (Brain) NP
Released when cardiac myofibrils are overstretched - effects to dec preload and after load by dec na and water retention and dec production of vasoconstricting peptides, inhibits sympathetic tone

Broad effects: Vasodilation, diuretic, antiproliferative properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Levels of BNP

A

<100 no HF
100-300 little indicator
300-600 mild HF
>600 mod HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of acute decompensated HF

A

Diuretics - dec preload, lasix
Vasodilation - dec preload and after load - nitro
Treat afib HR and contract with dig
Morphine to dec cardiac o2 demand and coronary vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do in acute HF when diuretics aren’t doing it

A

Inotropes
Milrinone - inotrope effects plus vasodilation dec preload and afterload
Dobutamine B1 for inotrope, min chronotropic effects, central vasodilation with B2 effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Symptoms of HF

A
Fluid overload SS 
Dyspnea 
Hemodynamic instability dec CO
Dysrhythmias
Embolisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnostic tests for HF

A
Labs
BNP, CK, Trop specific to HF
CBC, lyres, ur cr, ex lytes
Echo - EF
Coronary angiogram
ECG
CXR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NYHA Classification for HF

A

Class I mild EF<40% - Structural Heart disease, but Asymptomatic. treated with ACEi and BB to limit progress of disease with remodelling of myocardium
Class II mild EF ~35% - Symptomatic with moderate exertion - add dig, nitro, hydralazine, diuretics, spironolactone
Class III mod EF 35-25%- Symptomatic with min exertion - Above but considering ICD, CRT devices
Class IV severe EF <20- Symptomatic at rest - Goals of care?, transplant, IVAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why ACEi and BB in asymptomatic HF

A

slows remodelling of myocardium by limiting action of compensatory mechanisms which strain the heart, exacerbating HF. They decrease HR, contractility, dec afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Example of ARB

A

Angiotensin receptor blocker - Candesartan

Same effects as ACEi, just hits different part of pathway
Vasodilation - dec afterlaod, dec myocardial work and o2 demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example of aldosterone receptor blocker

A

Spironolocatone
Hits the other part of RAAS, stopping aldosterone from reabsorbing Na and H2O, thus diuretic effects. decreasing preload, leading to improved contractility, thus inc CO and o2 supply.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Meds classes to treat HF

A

*Rate Control: (dec myocardial work and O2 demand)
-BB - dec HR and contractility - dec myocardial work and o2demand, increase filling time
-Digoxin - suppress AV node conduction, dec HR, inc contractility a bit also by encouraging ca influx at membrane
*Vasodilators: (dec afterload, dec myocardial work and O2 demand)
-ACEi - vasodilation - reduced afterload - dec myocardial work and o2 demand
-ARB - vasodilation, dec afterload
Aldosterone Antagonist - diuretic
-Nitro - venous vasodilation - dec preload by increasing venous capacitance, mild arterial dilation dec afterload and inc coronary perfusion
*Diuretics - optimize/reduce preload and therefore contractility
-Lasix - loop diuretic K wasting - Optimize preload to increase contractility
-Spironolactone - Aldosterone receptor antagonist. stops RAAS retaining Na and H2O and allows diuresis (Na/Cl wasting, K sparing)
-Metolazone - inhibits reabsortion of Na, causing loss of H2o, K, Na, H+
*Inotropes
-Dig - limited inotropic effects as above
-Milrinone - improves contractility, vasodilator venous and arterial (dec preload, afterload and optimizes contractility)
-Dobutamine - B1 for inotrope, min chronotropic effects, central vasodilation with B2 effects (effects will be blocked by BB)

17
Q

Ventricular devices to support HF Class III&IV

A

-IABP (Intra Aortic Balloon Pump) - Balloon sits in aorta, inflates after each systole - forces blood into coronary arteries, deflates for systole, creating neg pressure in aorta for systole, drawing blood from the LV, dec cardiac workload, inc CO. Only for short term use
-Impella Micro Axial Flow device - actively pumps blood from LV into aorta - short term use goal to rest and recover LV
-ECMO - Extracorporeal membrane oxygenation - literally oxygenates and circulates blood usually via the fem vein and artery - used when lungs significantly compromised by edema (sig impacting oxygenation, and HF sufficiently advanced as there is minimal CO) - rest and recover heart and lung function
LVAD - replaces circulatory function of the LV, implanted with transplant in mind, can be used in the longish term

18
Q

Self management strategies for HF

A
Daily weights: come in if >2.5kg in a week, or 2kg in a day
Na restriction: 2-3g/day
H2O restriction: 1.5L/day
Exercise as tolerated
Take meds
19
Q

Implanted devices to manage HF

A

ICD - help prevent sudden cardiac death (major risk factor in HF) can overdrive pace, cardiovert, defibrillate, dual chamber pacing for bradycardias
CRT - cardiac resynchronization therapy - intraventricular conduction delays common in HF, leading to ventricular dysynchrony. Seen as Widened QRS. this device paces both ventricles synchronously, thereby improving EF and CO - recommended in EF <35% and QRS >0.12

20
Q

Surgical treatment of HF

A
  • Cardiac revascularization - CABG to repurfuse ischemic areas and recruit some extra contractility thus improving SV and CO
  • Transplantation - new heart, lots of issues with this tho, rejection, immune suppression, damage to new heart from existing causes of original heart failure
  • Valve replacement - reverses one of the causes of HF